Zhejiang Xingyue Biotechnology Co., Ltd., founded in 2010 with a registered capital of 40 million yuan, is a high-tech enterprise jointly established by a team of overseas-returned PhDs led by a National Distinguished Expert and private capital. The company is located in Hangzhou Future Sci-Tech City and is mainly engaged in the R&D and production of degradable implantable and interventional medical device products, while also cooperating with well-known Grade-A tertiary hospitals to carry out new technology services in regenerative medicine.
The company has invested a total of 200 million yuan and possesses a science and innovation park covering an area of 20 mu, with a 1,500-square-meter GMP production workshop and a 2,500-square-meter GMP laboratory. With the overseas-returned PhD team led by the National Distinguished Expert as its core, the company has an interdisciplinary talent team of young master's and doctoral graduates in biology, engineering, basic medicine, and clinical medicine from prestigious domestic universities. It currently has more than 30 R&D backbones, and the team has strong R&D strength.
After years of operation, the company has certain advantages in talent, facilities, major national projects, and industrialization progress, and has also gained high recognition within the industry, becoming one of the representative forces in this industry in Zhejiang Province and China.
Honors obtained and innovation platforms built by the company over the years:
1) Main undertaking unit of the National 12th Five-Year Plan "863" Project on Tissue Regeneration Technology; (2011)
2) Approved to build the Zhejiang Provincial Key Laboratory of Tissue Engineering and Regenerative Medicine Technology; (2012)
3) Approved to build the Zhejiang Provincial Key Enterprise Research Institute of Medical Materials and Tissue Engineering; (2012)
4) The R&D team was awarded the honorary title of "Zhejiang Provincial Key Science and Technology Innovation Team"; (2014)
5) Participating unit of the National 13th Five-Year Plan "863" Project on Intelligent Scaffold Materials; (2015)
6) Host unit of the Zhejiang Provincial Postdoctoral Research Workstation; (2016)
7) Awarded the Second Prize of Science and Technology of Shandong Province; (2019)
8) Awarded the First Prize of Technological Invention of the Ministry of Education of China; (2019)
Over the past decade, the team has conducted in-depth research on silk and found that silk has advantages such as good mechanical properties, good biocompatibility, and special biological activity. The company has carried out in-depth applied research on the new material—silk—in the medical field. At present, one silk fibroin wound dressing film has obtained a Class III product registration certificate. An implantable soft tissue repair product developed with silk as the main raw material is about to be submitted to the National Medical Products Administration for registration approval. In the future, the company will use silk as a platform material to accelerate the "replication" and superior substitution of internationally marketed polymer material products with good sales, and gradually realize the vision of "regenerating health through technology."
What does Zhejiang Xingyue Biotechnology Co., Ltd. require? Who is Zhejiang Xingyue Biotechnology Co., Ltd. hiring? recruitment: 销售类占比最多占59.5%,其次是市场/公关/媒介类占23.8%. What education can get in at ? 本科占比最多占57.1%,其次是大专占31%. High education required at ? 硕士占9.5%. Work experience required at ? 3-5年占比最多占40.5%,其次是5-10年占31%. Where are the job locations at ? 杭州占比最多占66.7%,其次是上海占4.8%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows